NCT04341103 (Al-COVE) is a clinical trial in Solid Organ Transplant Rejection, sponsored by CareDx.

Who is sponsoring NCT04341103?

NCT04341103 is sponsored by CareDx.

What condition does NCT04341103 study?

NCT04341103 studies Solid Organ Transplant Rejection, COVID-19.

Is NCT04341103 still recruiting?

NCT04341103 is currently status unknown. Last updated 10 April 2020.

Last reviewed 2020-04-10 · How we verify

NCT04341103: Al-COVE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience

Status unknown Last updated 10 April 2020

What this trial tests

trial in Solid Organ Transplant Rejection in 500 participants. Status unknown.

Timeline

1 April 2020

Primary endpoint
1 December 2020

1 March 2021

Quick facts

Lead sponsor	CareDx
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	1 April 2020
Primary completion	1 December 2020
Estimated completion	1 March 2021

Conditions studied

Solid Organ Transplant Rejection — all drugs for Solid Organ Transplant Rejection →
COVID-19 — all drugs for COVID-19 →

Sponsor

CareDx — full company profile →

Who can join

Eligibility, any sex, with Solid Organ Transplant Rejection or COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The utilization of AlloSure to help guide immunosuppression management in solid organ transplant recipients diagnosed with COVID-19

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other CareDx trials

Trials by the same sponsor.

NCT05050955 — AlloSure Lung Assessment and Metagenomics Outcomes Study · active not recruiting
NCT05033548 — Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient · terminated
NCT04635384 — Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test · active not recruiting
NCT04793360 — Molecular Assessment and Profiling of Liver Transplant Recipients · active not recruiting
NCT04601155 — Transition of Renal Patients Using AlloSure Into Community Kidney Care · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04341103 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CareDx
Last refreshed: 10 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04341103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing